Tengion Stock

Tengion FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Tengion (TNGNQ) as of Aug 11, 2026 is 91.19 %.

FCF Conversion

91.19 %

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Tengion is 2026 91.19 % . FCF Conversion Rate (FCF/EBITDA) of Tengion was 2025 - . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Tengion Stock analysis

What does Tengion do? Tengion Inc. is a biotechnology company specializing in the development and production of human organs and tissues. The company was founded in 2000 in Winston-Salem, North Carolina, and has since established various divisions to manufacture and market its products. Tengion's business model is based on the use of regenerative medicine technologies to produce functional human organs and tissues as alternative therapies for patients with organ failure or disease. The company aims to support the body's own regeneration rather than transplant organs. Tengion has gained recognition in the US and Europe for its "Neo-Kidney Augment" technology, which promotes the natural regeneration of kidney tissue. The company also has divisions for the development of tissues for regenerative medicine and offers innovative treatments for various diseases. Tengion employs a team of talented scientists and engineers who work with the latest technology and scientific methods. The company collaborates closely with academic institutions and research facilities to further develop and improve its technologies. The goal of Tengion is to establish a leading position in the development and production of human organs and tissues for regenerative medicine. Tengion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tengion stock

FCF Conversion Rate (FCF/EBITDA) of Tengion is 91.19 % in 2026.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Tengion since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Tengion with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Tengion

All Key Metrics — Tengion